While all the World Health Organization (WHO) regions remain committed to measles elimination, no region has achieved and sustained elimination targets of 95%.
And there have been significant decreases in measles-containing vaccine (MCV) coverage during the recent pandemic.
Among the WHO regions, the Southeast Asia Region faced the most significant decrease in first-dose MCV coverage (from 94% to 86%) between 2019 and 2021.
None of the WHO regions have recovered since 2019.
Expanding Measles Outbreaks in Many Countries
PTSD, Psychiatric Disorders Tied to Higher Risk for Severe COVID-19 Outcomes
Findings seen even when accounting for sociodemographic factors, comorbidities, and smoking
Study Looks at Extent of Residual Lung Abnormalities After COVID-19 Hospitalization
Posthospitalization prevalence of residual lung abnormalities estimated at 11.7 percent in sensitivity analyses
Poliovirus Investigation Integrates Michigan and Pennsylvania
During the summer of 2022, the state of New York (N.Y.) began investigating the presence of poliovirus in wastewater in various counties.
As of October 28, 2022, eight-two wastewater samples have been found genetically linked to the individual case of paralytic polio (Acute Flaccid Myelitis) in a Rockland County, N.Y., resident.
In response to the unknown risk, the U.S. Centers for Disease Control and Prevention (CDC) announced on November 30, 2022, that it would strategically expand poliovirus wastewater testing in select jurisdictions across the country.
Lyme Disease Vax Candidate Posts Positive Antibody Persistence Data
According to an announcement today, a Lyme disease vaccine candidate may soon obtain approval in the U.S. This would be significant since Lyme disease remains a serious health risk to most people.
This vector-borne illness is considered common in the Northern Hemisphere.
Each year, approximately 30,000 cases of Lyme disease are reported to U.S. CDC.
Earlier today, Pfizer Inc. and Valneva SE reported antibody persistence data six months after completing a three-dose or a two-dose vaccination schedule with their Lyme disease vaccine candidate.
Fewer Parents Talking to Child’s Regular Provider About Vaccines
Conversations less often about flu or COVID-19 vaccines versus school-required vaccines
Overactive Bladder Common in Postacute COVID-19 Syndrome
COVID-19 may lead to new or worsening urinary symptoms in men and women
Temporal Improvement Seen in Standard of Care for Hospitalized COVID-19 Patients
Outcomes improved from Adaptive COVID-19 Treatment Trial-2 to ACTT-3, although potential explanatory factors were similar
London Remains Focused on Polio Vaccinations
The U.K. Health Services Agency (UKHSA) recently published an update highlighting actions in response to detecting a VDPV2 in London sewage samples.
The UKHSA stated on November 14, 2022, primary care colleagues and immunization providers should ensure their patients are up to date with their polio-containing vaccines.
And offer catch-up vaccination to anyone who is un/under-vaccinated.
In the greater London area, an Inactivated Polio Vaccine booster campaign was launched targeting children aged one.
Cholera Vaccines Arrive in Syria
Since the recent cholera outbreak was declared in Syria in September 2022, tens of thousands of suspected acute watery diarrhea (AWD) cases have been reported in all governorates.
The World Health Organization (WHO) announced some positive news on November 29, 2022, trucks carrying about two million doses of Oral Cholera Vaccines (OCV) have arrived in Damascus, Syria.
These OCVs will be used in an immunization campaign starting on December 4, 2022, to reach vulnerable people in the highly affected governorates: Aleppo, Ar-Raqqa Al -Hassakeh, and Deir ez-Zor.